Aspect Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$140K Sell
332
-1
-0.3% -$399 0.05% 96
2026
Q2
$121K Hold
333
– – 0.05% 103
2026
Q1
$117K Hold
333
– – 0.05% 97
2025
Q4
$109K Sell
333
-244
-42% -$77.4K 0.05% 101
2025
Q3
$163K Sell
577
-410
-42% -$119K 0.07% 86
2025
Q2
$276K Buy
987
+409
+71% +$116K 0.14% 66
2025
Q1
$180K Hold
578
– – 0.1% 73
2024
Q4
$151K Sell
578
-1
-0.2% -$297 0.09% 80
2024
Q3
$187K Hold
579
– – 0.1% 69
2024
Q2
$181K Hold
579
– – 0.11% 74
2024
Q1
$165K Hold
579
– – 0.13% 75
2023
Q4
$167K Buy
+579
New +$158K 0.11% 73

Other funds holding AMGN

Aspect Partners's AMGN Position: Q3 2026 in Review

Aspect Partners reduced its Amgen (AMGN) stake by 0.3% in Q3 2026, selling an estimated $399 and leaving 332 shares worth $140K. The position accounts for 0.05% of the portfolio, ranked #96.

Aspect Partners first reported a position in AMGN in Q4 2023 and has held it in 12 quarters since. The position peaked at $276K in Q2 2025. 1,006 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Aspect Partners held 332 shares of Amgen worth $140K as of Q3 2026.
  • Aspect Partners sold 1 Amgen share in Q3 2026, an estimated $399.
  • Amgen made up 0.05% of Aspect Partners's portfolio in Q3 2026, its #96 holding.
  • Aspect Partners first reported a position in Amgen in Q4 2023 and has held it in 12 quarters since.
  • Aspect Partners's Amgen position peaked at $276K in Q2 2025.
  • 1,006 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Aspect Partners's 13F filing for Q3 2026, filed 20 Oct 2026.